| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 14.813 | 11.431 | 5.607 | 3.223 | 2.318 | 7.220 | 6.098 | 6.519 | - | - |
| Total Income - EUR | 14.813 | 11.431 | 5.607 | 3.223 | 2.318 | 19.831 | 6.098 | 6.519 | - | - |
| Total Expenses - EUR | 14.234 | 1.945 | 2.138 | 11.642 | 19.719 | 18.385 | 3.189 | 638 | - | - |
| Gross Profit/Loss - EUR | 578 | 9.486 | 3.469 | -8.419 | -17.401 | 1.446 | 2.909 | 5.882 | - | - |
| Net Profit/Loss - EUR | 0 | 9.143 | 3.301 | -8.515 | -17.471 | 851 | 2.726 | 5.702 | - | - |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | - | - |
Check the financial reports for the company - Laura Anca Dermatology Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 5.207 | 28.272 | 21.776 | 15.211 | 10.313 | 0 | 0 | 0 | - | - |
| Current Assets | 1.085 | 1.609 | 1.582 | 258 | 138 | 33 | 323 | 341 | - | - |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - |
| Receivables | 434 | 430 | 422 | 0 | 0 | 0 | 0 | 0 | - | - |
| Cash | 651 | 1.180 | 1.160 | 258 | 138 | 33 | 323 | 341 | - | - |
| Shareholders Funds | -6.980 | 9.188 | 3.345 | -8.472 | -17.429 | -16.247 | -13.161 | -7.499 | - | - |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | - | - |
| Debts | 13.272 | 20.694 | 20.013 | 23.942 | 27.880 | 16.280 | 13.483 | 7.840 | - | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Laura Anca Dermatology Srl